EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Journal of Hematology & Oncology

ISSN 1756-8722 · Springer Science and Business Media LLC

Latest articles

  1. Dual-targeting BCMA/CD19 CAR T cells with asymmetric 4-1BB/CD28-YMFM costimulation in relapsed/refractory multiple myeloma: a phase 1/2 trial with single-cell profiling of extramedullary disease

    Hua Jiang, Lu Li, Chunchen Yang, Kaili Chen, Liangyu Xie, Ruixue Ma, Yaqin Lu, Can He, Fang Feng, Xiaoran Mei, Hao Wu, Xiaomei Chen, Dan Li, Xing Xiao, Xianghai Cai, Tao Zhou, Hui Yuan, Zhiyou Zhou, Xiaoping Ye, Jin Zhao, Tao Guan, Li Ma, Min Bai, Guoxiang Wu, Liping Su, Weijun Fu

    Published: 2026-11-18DOI: 10.1186/s13045-026-01870-y

  2. Upfront venetoclax plus quizartinib with low-dose cytarabine or azacitidine in older unfit patients with acute myeloid leukemia: the phase I/II VEN-A-QUI trial

    Juan Miguel Bergua, Pilar Lloret-Madrid, Rebeca Rodríguez-Veiga, Isabel Cano-Ferri, Ferran Vall-llovera, Antonio García-Guiñón, Joaquín Gómez-Espuch, Mercedes Colorado, Ignacio Casas-Avilés, Jordi Esteve, Antonia Sampol, María V. Verdugo, Ágata Almela, Marta Valero, Evelyn Acuña-Cruz, Blanca Boluda, Laura Torres, Joaquín Martínez-López, Eva Barragán, Teresa Cedena, Rosa Ayala, Beatriz Martín-Herreros, Bruno Paiva, David Martínez-Cuadrón, Pau Montesinos

    Published: 2026-11-15DOI: 10.1186/s13045-026-01868-6

  3. A phase 1 trial of CD123-directed chimeric antigen receptor T-cell therapy in adults with relapsed/refractory acute myeloid leukemia or blastic plasmacytoid dendritic cell neoplasm

    Lihua E. Budde, Marissa M. Del Real, Joo Song, Tracey Stiller, Yan Wang, Ahmed Aribi, Karamjeet Sandhu, Ryotaro Nakamura, Emanuela C. Marcucci, Jian J. Wu, Kenneth Ng, Mary C. Clark, Brent Wood, Jamie R. Wagner, Jinny Paul, Christine E. Brown, Anthony Stein, Guido Marcucci, M. Suzette Blanchard, Joycelynne Palmer, Stephen J. Forman

    Published: 2026-08-07DOI: 10.1186/s13045-026-01833-3

  4. CD20 expression dynamics in adult B-cell acute lymphoblastic leukemia and impact on anti-CD20 treatment

    Monika Szczepanowski, Johanna Richter, Sonja Bendig, Lorenz Bastian, Miriam Kelm, Veronika Beck, Thomas Beder, Guranda Chitadze, Michaela Kotrová, Johannes Duell, Christoph Faul, Johannes Gärtner, Alina Hartmann, Britta Kehden, Eva Maria Murga Penas, Martin Neumann, Matthias Ritgen, Wiebke Schrader, Björn Steffen, Heiko Trautmann, Andreas Viardot, Thomas Burmeister, Claudia D. Baldus, Stefan Schwartz, Nicola Gökbuget, Monika Brüggemann

    Published: 2026-07-20DOI: 10.1186/s13045-026-01832-4

  5. Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm

    Guillaume Cartron, Isabelle Chaillol, Roch Houot, Yassine Al Tabaa, Fabien Le Bras, Loïc Ysebaert, Sylvain Choquet, Fabrice Jardin, Jacques-Olivier Bay, François-Xavier Gros, Franck Morschhauser, Cédric Rossi, Thomas Gastinne, Catherine Thieblemont, Magalie Joris, Laure Ricard, Caroline Regny, Laurianne Drieu La Rochelle, Pierre Feugier, Ambroise Marcais, Romain Ould-Ammar, Karin Tarte, Camille Laurent, Pierre Sesques

    Published: 2026-07-01DOI: 10.1186/s13045-026-01816-4

Volumes

2026 · 1022025 · 1182024 · 1322023 · 1232022 · 1782021 · 2062020 · 1742019 · 1452018 · 1432017 · 1752016 · 1382015 · 1312014 · 952013 · 942012 · 832011 · 542010 · 512009 · 572008 · 27

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.